Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 5 |
| List of Tables | 4 | 2 |
| List of Figures | 6 | 1 |
| Wellcome Trust, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016 | 6 | 2 |
| Wellcome Trust, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 2016 | 8 | 1 |
| Wellcome Trust, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 2016 | 9 | 1 |
| Wellcome Trust, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 2016 | 10 | 2 |
| Wellcome Trust, Medical Devices Deals, 2010 to YTD 2016 | 12 | 1 |
| Wellcome Trust, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016 | 13 | 5 |
| Wellcome Trust, Pharmaceuticals &Healthcare, Deal Details | 18 | 54 |
| Venture Financing | 18 | 1 |
| Cambridge Epigenetix Raises USD21 Million in Series B Financing | 18 | 2 |
| Freeline Therapeutics to Raise USD38 Million in Series A Financing | 20 | 1 |
| NightstaRx Raises USD35 Million in Series B Financing Round | 21 | 1 |
| Nabriva Therapeutics Raises USD120 Million in Series B Financing | 22 | 2 |
| Nightstar Raises Additional USD8.2 Million in Venture Financing Round | 24 | 1 |
| Autolus Raises USD45.4 Million in Series A Financing | 25 | 1 |
| 14M Genomics Raises USD19.6 Million in Venture Financing | 26 | 1 |
| Cambridge Epigenetix Raises USD5.5 Million in Series A Venture Financing | 27 | 1 |
| Kymab Raises USD40 Million in Series B Financing | 28 | 2 |
| Blue Earth Diagnostics Raises US$21.3 Million In Venture Financing | 30 | 1 |
| NightstaRx Raises US$19.8 Million In Venture Financing | 31 | 1 |
| Pcovery Raises USD4 Million in Venture Financing | 32 | 1 |
| Biocartis Raises US$40.5 Million In Series E Financing | 33 | 2 |
| Pcovery Raises USD5.7 Million in Seed Financing | 35 | 1 |
| Trino Therapeutics Raises US$12 Million In Series A Financing | 36 | 2 |
| Canbex Therapeutics Raises US$3 Million In Venture Financing | 38 | 2 |
| Radius Health Secures US$21.4 Million In Third Tranche Of Financing Round | 40 | 3 |
| Biocartis Secures US$96 Million In Series C Financing Round | 43 | 2 |
| Population Genetics Technologies Secures US$6 Million In Series B Financing | 45 | 2 |
| Cell Biosciences Secures US$20 Million In Series F Venture Financing | 47 | 2 |
| Kymab Raises US$25 Million In Series A Financing Round | 49 | 1 |
| Oxagen Raises US$33 Million In Series C Financing | 50 | 3 |
| Achaogen Raises US$56 Million In Series C Financing Round | 53 | 2 |
| Partnerships | 55 | 1 |
| Sigma-Aldrich Enters into Agreement with Sanger Institute | 55 | 1 |
| AstraZeneca Enters into Research Agreement with Wellcome Trust Sanger Institute | 56 | 1 |
| UCL Business Forms Joint Venture with Syncona | 57 | 1 |
| Merck Serono Enters into Co-Development Agreement with Institute of Cancer Research and Wellcome Trust | 58 | 1 |
| Katholieke Universiteit Leuven And Wellcome Trust Enter Into Agreement With Janssen Pharma To Develop Dengue Antiviral Drugs | 59 | 2 |
| Illumina Enters Into Co-Development Agreement With Wellcome Trust Sanger Institute | 61 | 1 |
| Horizon Discovery Enters Into Collaboration With Wellcome Trust Sanger Institute | 62 | 1 |
| Agilent Technologies Enters Into Co-Development Agreement With Wellcome Trust Sanger Institute and Gencode | 63 | 1 |
| Department of Biotech Enters Into Co-Development Agreement With Wellcome Trust | 64 | 1 |
| Licensing Agreements | 65 | 1 |
| Basilea Pharma Enters into Licensing Agreement for Novel PanRAF Kinase Inhibitors | 65 | 2 |
| Oxford Gene Enters into Licensing Agreement with Wellcome Trust Sanger Institute | 67 | 1 |
| Acquisition | 68 | 1 |
| Ergomed Acquires Haemostatix | 68 | 2 |
| GlaxoSmithKline Acquires Remaining Stake in GlycoVaxyn for USD190 Million | 70 | 2 |
| Wellcome Trust - Key Competitors | 72 | 1 |
| Key Employees | 73 | 1 |
| Locations And Subsidiaries | 74 | 1 |
| Head Office | 74 | 1 |
| Other Locations &Subsidiaries | 74 | 1 |
| Appendix | 75 | 1 |
| Methodology | 75 | 1 |
| About GlobalData | 75 | 1 |
| Contact Us | 75 | 1 |
| Disclaimer | 75 | 1 |